BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12923381)

  • 1. Adenocarcinoma in situ arising from the submucosal oesophageal mucous glands.
    Fabre A; Tansey DK; Dave U; Wright M; Teare JP; Rosin DR; Thompson ME
    Eur J Gastroenterol Hepatol; 2003 Sep; 15(9):1047-9. PubMed ID: 12923381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paget's disease of the oesophagus associated with mucous gland carcinoma of the lower oesophagus.
    Haleem A; Kfoury H; Al Juboury M; Al Husseini H
    Histopathology; 2003 Jan; 42(1):61-5. PubMed ID: 12493026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oesophageal and gastric pathology: early neoplastic lesions. case 2 and case 3. Dysplasia and superficial cancer on Barrett's oesophagus].
    Fléjou JF
    Ann Pathol; 2011 Oct; 31(5):363-8. PubMed ID: 21982243
    [No Abstract]   [Full Text] [Related]  

  • 4. The utility of cytokeratin subsets in distinguishing Barrett's-related oesophageal adenocarcinoma from gastric adenocarcinoma.
    Ormsby AH; Goldblum JR; Rice TW; Richter JE; Gramlich TL
    Histopathology; 2001 Apr; 38(4):307-11. PubMed ID: 11318895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant transformation of esophageal columnar epithelium.
    Berenson MM; Riddell RH; Skinner DB; Freston JW
    Cancer; 1978 Feb; 41(2):554-61. PubMed ID: 204408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential up-regulation of heparanase and cyclooxygenase-2 in carcinogenesis of Barrett's oesophagus and intestinal-type gastric carcinoma.
    Sonoda R; Naomoto Y; Shirakawa Y; Fujiwara Y; Yamatsuji T; Noma K; Tanabe S; Takaoka M; Gunduz M; Tsujigiwa H; Nagatsuka H; Ohara N; Yoshino T; Takubo K; Vieth M; Tanaka N
    Histopathology; 2010 Jul; 57(1):90-100. PubMed ID: 20653782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ductal metaplasia in oesophageal submucosal glands is associated with inflammation and oesophageal adenocarcinoma.
    Garman KS; Kruger L; Thomas S; Swiderska-Syn M; Moser BK; Diehl AM; McCall SJ
    Histopathology; 2015 Dec; 67(6):771-82. PubMed ID: 25847432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of endocrine cells, dysplasia and carcinoembryonic antigen in Barrett's mucosa to adenocarcinoma of the oesophagus.
    Griffin M; Sweeney EC
    Histopathology; 1987 Jan; 11(1):53-62. PubMed ID: 2881873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrett's oesophagus: the new endoscopic modalities have a future.
    Deviere J
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i33-7. PubMed ID: 15711006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GATA6 expression in Barrett's oesophagus and oesophageal adenocarcinoma.
    Pavlov K; Honing J; Meijer C; Boersma-van Ek W; Peters FT; van den Berg A; Karrenbeld A; Plukker JT; Kruyt FA; Kleibeuker JH
    Dig Liver Dis; 2015 Jan; 47(1):73-80. PubMed ID: 25445407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia.
    Tanaka M; Ushiku T; Ikemura M; Shibahara J; Seto Y; Fukayama M
    Pathol Int; 2014 Aug; 64(8):397-401. PubMed ID: 25143128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer risk in Barrett's oesophagus.
    Dias Pereira A; Suspiro A; Chaves P
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):915-8. PubMed ID: 18049157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early adenocarcinoma of the oesophagus and oesophageal cyst.
    Santacroce CM; Fléjou JF
    Histopathology; 1997 Jul; 31(1):87-90. PubMed ID: 9253630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.
    Shivappa N; Hebert JR; Anderson LA; Shrubsole MJ; Murray LJ; Getty LB; Coleman HG
    Br J Nutr; 2017 May; 117(9):1323-1331. PubMed ID: 28571591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus.
    Pech O; Behrens A; May A; Nachbar L; Gossner L; Rabenstein T; Manner H; Guenter E; Huijsmans J; Vieth M; Stolte M; Ell C
    Gut; 2008 Sep; 57(9):1200-6. PubMed ID: 18460553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.
    Pohl H; Pech O; Arash H; Stolte M; Manner H; May A; Kraywinkel K; Sonnenberg A; Ell C
    Gut; 2016 Feb; 65(2):196-201. PubMed ID: 26113177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A family history of Barrett's oesophagus: another risk factor?
    Groves C; Jankowski J; Barker F; Holdstock G
    Scand J Gastroenterol; 2005 Sep; 40(9):1127-8. PubMed ID: 16211720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coamplification and coexpression of GRB7 and ERBB2 is found in high grade intraepithelial neoplasia and in invasive Barrett's carcinoma.
    Walch A; Specht K; Braselmann H; Stein H; Siewert JR; Hopt U; Höfler H; Werner M
    Int J Cancer; 2004 Dec; 112(5):747-53. PubMed ID: 15386389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: Barrett's oesophagus and carcinoma in Japan.
    Hongo M
    Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():50-4. PubMed ID: 15575874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oesophageal and gastric pathology: early neoplastic lesions. case 1: squamous intraepithelial neoplasia of the oesophagus].
    Chatelain D; Fléjou JF
    Ann Pathol; 2011 Oct; 31(5):356-62. PubMed ID: 21982242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.